Jon Gingrich News Today

/PRNewswire/ -- The American Association for the Study of Liver Disease (AASLD) has released new guidance advocating noninvasive tests like FibroScan® for the...

Healthcare

Healthcare

/PRNewswire/ -- The growing prevalence of fatty liver disease in the U.S. has led the American Association for the Study of Liver Diseases (AASLD) to call for...

Echosens, a high-technology company offering liver diagnostic solutions, is pleased to announce its strong presence at the upcoming American Association for the Study of Liver Diseases (AASLD) Liver

WALTHAM, Mass. & FORT LAUDERDALE, Fla. (PRWEB) October 24, 2022 -- Echosens North America, a high-technology company offering the FibroScan® portfolio of

June 23, ExCel London Center, London Echosens, a high-technology company offering the FibroScan portfolio of solutions, is pleased to announce its solutions will be included in 22 oral presentations

Cost-effective, non-invasive tool for early detection, monitoring of liver disease Echosens, a high-technology company offering the FibroScan portfolio of solutions, is pleased to announce that

Echosens Launches New FibroScan-Based Scores Agile 3+ & Agile 4: Identifies Advanced Fibrosis and Cirrhosis, Predicts Clinical Outcomes, Improves Patient Management Echosens, a high-technology company offering the FibroScan family of products, today announces the global launch of FibroScan-based Agile scores to easily detect advanced fibrosis and cirrhosis in non-alcoholic fatty liver disease (NAFLD) patients, reduce the number of false positive cases compared to liver stiffness measuremen...

As part of its 20th anniversaryEchosens, a high-technology company offering the FibroScanfamily of products, is pleased to announce its sponsorship of the first annual Liver Health Matters Month, an